½ÃÀ庸°í¼­
»óǰÄÚµå
1346919

µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® ¸®Æ÷Æ® : µ¿¹° À¯Çüº°, Á¦Ç° À¯Çüº°, ¿ëµµº°, Áúȯ À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals); By Product Type; By Application; By Disease Type; By Region, And Segment Forecasts, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 25¾ï 5,479¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ÇöÀçÀÇ ½ÃÀå ¿ªÇÐÀ» »ó¼¼È÷ ÀλçÀÌÆ®Çϰí, ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº µ¿¹°ÀÇ ±Þ¼º ¹× ¸¸¼ºÁúȯ ¹ßº´·ü Áõ°¡¿Í Á¤È®µµ°¡ Çâ»óµÈ °í±Þ Áø´Ü ¹× ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¹Ì±¹ ¼öÀÇ»çÇùȸ¿¡ µû¸£¸é ¹Ý·Á°ßÀÇ Àý¹Ý °¡±îÀ̰¡ Àΰ£°ú ºñ½ÁÇÑ ºñÀ²·Î ¾Ï¿¡ °É¸°´Ù°í ÇÕ´Ï´Ù. ÀÌ´Â Áúº´À» Àû½Ã¿¡ ¿¹ÃøÇϰí È¿°úÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿¸¦ ±â¹ÝÀ¸·Î ÇÑ Æ¯¼ö Áø´Ü ŰƮÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

½ÅÈï ±¹°¡°ú ¼±Áø±¹ ¸ðµÎ¿¡¼­ µ¿¹° ÀÇ·á¿¡ ´ëÇÑ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ëÀÇ Å« ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â ¹Ì±¹¾Ö°ßÇùȸ(AKC)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¹Ý·Áµ¿¹°ÀÇ °Ç°­ ¹× °Ç°­°ü¸® Á¦Ç°¿¡ ÅõÀÚÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ ¹Ý·Áµ¿¹°¿ëǰÇùȸ(American Pet Products Association)´Â ¹Ý·Áµ¿¹° »ê¾÷ Àüü ¸ÅÃâÀÌ 2022³â ¸»±îÁö 1¾ï 4,000¸¸ ´Þ·¯¸¦ µ¹ÆÄÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¹°¿ë ÀǾàǰ ºÐ¾ß, ƯÈ÷ ¹ÙÀÌ¿À¸¶Ä¿¿Í °°Àº ºÐ¾ß´Â Áö³­ 10³â°£ ¸¹Àº ¿¬±¸¿Í °³¹ßÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ°í ¹ßÀü¿¡ À¯¸®ÇÑ Á¶°ÇÀ» Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µ¿¹° ÀÇ·á »ê¾÷Àº COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¸¶ÄÉÆÃ ¹× ÆÇ¸Å Ȱµ¿ Áß´Ü, µ¿¹°º´¿ø ¹æ¹® °¨¼Ò, Á¤±âÀûÀÎ ¹Ý·Áµ¿¹° °ËÁø Ãë¼Ò, µ¿¹°º´¿ø¿¡¼­ ½ÃÇàµÇ´Â Áø´Ü °Ë»ç °¨¼Ò µî Å« À庮°ú ¹®Á¦¿¡ Á÷¸éÇß½À´Ï´Ù. ±×·¯³ª °¢±¹ Á¤ºÎ¿Í µ¿¹°´ÜüµéÀº COVID-19 ÆÒµ¥¹Í ¼Ó¿¡¼­ µ¿¹° Áø·á ¹× °ü·Ã ¿¬±¸ Ȱµ¿À» Àç°³Çϱâ À§ÇÑ Àü·«°ú ¾ÈÀü Á¶Ä¡¸¦ ½ÃÇàÇß½À´Ï´Ù. Æó¼âÀÇ ¿µÇâÀ» ÁÙÀ̱â À§ÇØ µ¿¹°º´¿ø ¹× Áø·á¼Ò¿¡¼­ ¿ø°Ý Áø·á ¼­ºñ½º°¡ ³Î¸® äÅÃµÇ¾î ¿ø°Ý Áø·á¿Í Áø´ÜÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ ¹Ý·Áµ¿¹° º¸È£ÀÚ¿¡°Ô ƯÁ¤ Áø´Ü ŰƮ »ç¿ë¹ýÀ» µðÁöÅзΠ±³À°ÇÏ¿© ¿ø°ÝÀ¸·Î Áø´Ü °úÁ¤¿¡ Âü¿©ÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù.

µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹Ý·Áµ¿¹° ¼¼ºÐÈ­°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÕ´Ï´Ù.

ƯÁ¤ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ã±â À§ÇÑ À¯Àüü ±â¼úÀÇ ¹ßÀüÀ¸·Î ¹ÙÀÌ¿À¸¶Ä¿ ¹× ŰƮ ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

Çõ½ÅÀûÀÎ ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý °Ë»ç ŰƮ Ãâ½Ã·Î Áúº´ Áø´Ü ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ºÏ¹Ì°¡ ½ÃÀå ÁÖµµ, ¼ÒºñÀÚ ÀÎÁöµµ¿Í ¹Ý·Áµ¿¹°ÀÇ ³ôÀº º¸±Þ·ü

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ÀλçÀÌÆ®

  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ÁúȯÀÇ À¯Çü ½º³À¼ô
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
      • µ¿¹°¿¡¼­ ¾Ï ¹× ½ÉÇ÷°üÁúȯ µî ¸¸¼ºÁúȯÀÇ ¹ß»ý·ü »ó½ÂÀº ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý ¾î¼¼ÀÌ Áø´Ü ŰƮÀÇ ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇÏ´Â ¿äÀÎ
      • Áø´ÜÀÇ Áøº¸
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Ç¥ÁØÈ­¿Í °ËÁõ¿¡¼­ÀÇ °úÁ¦°¡ ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÑ´Ù.
  • PESTEL ºÐ¼®
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Áúȯ À¯ÇüÀÇ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¹Ý·Áµ¿¹°
  • »ý»ê µ¿¹°

Á¦6Àå ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¹ÙÀÌ¿À¸¶Ä¿, ŰƮ, ½Ã¾à
  • ¹ÙÀÌ¿À¸¶Ä¿ ¸®´õ

Á¦7Àå ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¿°Áõ ¹× °¨¿°Áõ
  • ½ÉÇ÷°üÁúȯ
  • °ñ°Ý±Ù Áúȯ
  • Á¾¾ç
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Æò°¡, Áö¿ª, 2019-2032³â
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¹Ì±¹
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ij³ª´Ù
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - À¯·´
    • À¯·´ : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
    • À¯·´ : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
    • À¯·´ : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¿µ±¹
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ÇÁ¶û½º
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - µ¶ÀÏ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ÀÌÅ»¸®¾Æ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ½ºÆäÀÎ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ³×´ú¶õµå
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ·¯½Ã¾Æ
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Áß±¹
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Àεµ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¸»·¹À̽þÆ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ÀϺ»
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Àεµ³×½Ã¾Æ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Çѱ¹
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - À̽º¶ó¿¤
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¸ß½ÃÄÚ
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ºê¶óÁú
    • µ¿¹°¿ë ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®Àå°ú Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • ACUVET BIOTECH
  • Antech Diagnostics
  • Avacta Animal Health
  • IDEXX Laboratories
  • Life Diagnostic
  • Merck
  • Mercodia
  • MI : RNA Diagnostics
  • Virbac
  • Zoetis
KSA 23.10.18

The global veterinary biomarkers market size is expected to reach USD 2,554.79 million by 2032, according to a new study by Polaris Market Research. The report "Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals), By Product Type, By Application, By Disease Type, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market growth is primarily driven by the rising incidence of acute and chronic diseases in animals, alongside the growing demand for advanced diagnostic and monitoring technologies with improved accuracy. The American Veterinary Medical Association reports that nearly half of the dog population is experiencing cancer at a similar rate to humans. This highlights the need for specialized diagnostic kits based on biomarkers, enabling timely disease prediction and effective treatments.

Growing expenditure on animal care in both developing and developed economies presents a substantial opportunity for market expansion. In the United States, pet owners have been increasingly investing in the wellness and healthcare products for their pets, as indicated by data from the American Kennel Club (AKC). The American Pet Products Association also reported that the sales in the overall pet industry surpassed USD 140 million by the end of 2022. Moreover, there has been significant research and development activity in the veterinary field, particularly in areas such as biomarkers, over the past decade. These factors are anticipated to drive the growth of the market, providing favorable conditions for its advancement.

Animal health industry faced significant barriers and challenges during the COVID-19 pandemic, including disruptions in marketing and sales activities, reduced veterinary clinic visits, cancellations of routine pet check-ups, and a decrease in diagnostic tests conducted in veterinary hospitals. However, governments & veterinary organizations in different countries implemented strategies & safety measures to resume the veterinary practices &relevant research activities amidst the pandemic. To mitigate the impact of lockdowns, telemedicine services were widely adopted in veterinary clinics and hospitals, allowing remote consultations and diagnoses. Additionally, pet owners were provided with digital training to use specific diagnostic kits, enabling them to participate in the diagnostic process remotely.

Veterinary Biomarkers Market Report Highlights

Companion animal segment held the largest share, primarily high adoption rate of cats & dogs in developed nations

Biomarker & kits segment dominated the market, due to the advancements in genomic technologies to find specific biomarkers

Disease diagnostics segment garnered the largest share, owing to launch of innovative biomarker-based test kits

North America led the market, with awareness among consumers and high adoption rate of pets

The global key market players include: Merck, Zoetis, ACUVET BIOTECH, IDEXX Laboratories, Virbac, and Life Diagnostics.

Polaris Market Research has segmented the veterinary biomarkers market report based on animal type, product type, application, disease type, and region:

Veterinary Biomarkers, Animal Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Companion Animals
  • Dogs
  • Cats
  • Others
  • Production Animals
  • Cows
  • Pigs
  • Others

Veterinary Biomarkers, Product Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Biomarkers, Kits & Reagents
  • Biomarker Readers

Veterinary Biomarkers, Application Outlook (Revenue - USD Million, 2023 - 2032)

  • Disease Diagnostics
  • Preclinical Research
  • Others

Veterinary Biomarkers, Disease Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Inflammatory & Infectious Diseases
  • Cardiovascular Diseases
  • Skeletal Muscle Diseases
  • Tumor
  • Others

Veterinary Biomarkers, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Biomarkers Market Insights

  • 4.1. Veterinary Biomarkers Market - Disease Type Snapshot
  • 4.2. Veterinary Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of chronic conditions like cancer and cardiovascular diseases among animals is a significant driver for the demand of biomarker-based assay diagnostic kits
      • 4.2.1.2. Advancements in Diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Challenges in Standardization and Validation of Veterinary Biomarkers Hampers Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Biomarkers Market Disease Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Biomarkers Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
  • 5.3. Companion Animals
    • 5.3.1. Global Veterinary Biomarkers Market, by Companion Animals, by Region, 2019-2032 (USD Million)
    • 5.3.2. Dogs
      • 5.3.2.1. Global Veterinary Biomarkers Market, by Dogs, by Region, 2019-2032 (USD Million)
    • 5.3.3. Cats
      • 5.3.3.1. Global Veterinary Biomarkers Market, by Cats, by Region, 2019-2032 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Global Veterinary Biomarkers Market, by Others, by Region, 2019-2032 (USD Million)
  • 5.4. Production Animals
    • 5.4.1. Global Veterinary Biomarkers Market, by Production Animals, by Region, 2019-2032 (USD Million)
    • 5.4.2. Cows
      • 5.4.2.1. Global Veterinary Biomarkers Market, by Cows, by Region, 2019-2032 (USD Million)
    • 5.4.3. Pigs
      • 5.4.3.1. Global Veterinary Biomarkers Market, by Pigs, by Region, 2019-2032 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Global Veterinary Biomarkers Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Veterinary Biomarkers Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
  • 6.3. Biomarkers, Kits & Reagents
    • 6.3.1. Global Veterinary Biomarkers Market, by Biomarkers, Kits & Reagents, by Region, 2019-2032 (USD Million)
  • 6.4. Biomarker Readers
    • 6.4.1. Global Veterinary Biomarkers Market, by Biomarker Readers, by Region, 2019-2032 (USD Million)

7. Global Veterinary Biomarkers Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
  • 7.3. Inflammatory & Infectious Diseases
    • 7.3.1. Global Veterinary Biomarkers Market, by Inflammatory & Infectious Diseases, By Region, 2019-2032 (USD Million)
  • 7.4. Cardiovascular Diseases
    • 7.4.1. Global Veterinary Biomarkers Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
  • 7.5. Skeletal Muscle Diseases
    • 7.5.1. Global Veterinary Biomarkers Market, by Skeletal Muscle Diseases, By Region, 2019-2032 (USD Million)
  • 7.6. Tumor
    • 7.6.1. Global Veterinary Biomarkers Market, by Tumor, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Veterinary Biomarkers Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Veterinary Biomarkers Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Veterinary Biomarkers Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Veterinary Biomarkers Market - North America
    • 8.3.1. North America: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
    • 8.3.3. North America: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.4. Veterinary Biomarkers Market - U.S.
      • 8.3.4.1. U.S.: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.5. Veterinary Biomarkers Market - Canada
      • 8.3.5.1. Canada: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
  • 8.4. Veterinary Biomarkers Market - Europe
    • 8.4.1. Europe: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
    • 8.4.3. Europe: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.4. Veterinary Biomarkers Market - UK
      • 8.4.4.1. UK: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.5. Veterinary Biomarkers Market - France
      • 8.4.5.1. France: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.5.3. France: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.6. Veterinary Biomarkers Market - Germany
      • 8.4.6.1. Germany: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.7. Veterinary Biomarkers Market - Italy
      • 8.4.7.1. Italy: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.8. Veterinary Biomarkers Market - Spain
      • 8.4.8.1. Spain: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.9. Veterinary Biomarkers Market - Netherlands
      • 8.4.9.1. Netherlands: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.10. Veterinary Biomarkers Market - Russia
      • 8.4.10.1. Russia: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
  • 8.5. Veterinary Biomarkers Market - Asia Pacific
    • 8.5.1. Asia Pacific: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.4. Veterinary Biomarkers Market - China
      • 8.5.4.1. China: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.4.3. China: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.5. Veterinary Biomarkers Market - India
      • 8.5.5.1. India: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.5.3. India: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.6. Veterinary Biomarkers Market - Malaysia
      • 8.5.6.1. Malaysia: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.7. Veterinary Biomarkers Market - Japan
      • 8.5.7.1. Japan: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.8. Veterinary Biomarkers Market - Indonesia
      • 8.5.8.1. Indonesia: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.9. Veterinary Biomarkers Market - South Korea
      • 8.5.9.1. South Korea: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
  • 8.6. Veterinary Biomarkers Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.4. Veterinary Biomarkers Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.5. Veterinary Biomarkers Market - UAE
      • 8.6.5.1. UAE: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.6. Veterinary Biomarkers Market - Israel
      • 8.6.6.1. Israel: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.7. Veterinary Biomarkers Market - South Africa
      • 8.6.7.1. South Africa: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
  • 8.7. Veterinary Biomarkers Market - Latin America
    • 8.7.1. Latin America: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.4. Veterinary Biomarkers Market - Mexico
      • 8.7.4.1. Mexico: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.5. Veterinary Biomarkers Market - Brazil
      • 8.7.5.1. Brazil: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.6. Veterinary Biomarkers Market - Argentina
      • 8.7.6.1. Argentina: Veterinary Biomarkers Market, by Animal Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Veterinary Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Veterinary Biomarkers Market, by Product Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. ACUVET BIOTECH
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Antech Diagnostics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Avacta Animal Health
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. IDEXX Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Life Diagnostic
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mercodia
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. MI:RNA Diagnostics
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Virbac
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Zoetis
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦